KATELYN LARSEN: Open Payments
NPI 1366701955 · COUNCIL BLUFFS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 27 payments from 11 companies in 2025. Trend: 2023 $388 · 2024 $635 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $145 |
| PFIZER INC. | 3 | $51 |
| Stryker Corporation | 1 | $47 |
| Verona Pharma, Inc. | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Novo Nordisk Inc | 1 | $26 |
| Lundbeck LLC | 1 | $23 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Amgen Inc. | 1 | $14 |
Products named: QULIPTA, VARIAX, UBRELVY, Ohtuvayre, Ozempic, REXULTI, VRAYLAR, JOURNAVX.
Industry payments across IA — which companies pay providers there.
